Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Takasago International is a global leader in the flavor and fragrance industry, with a significant presence in the pharmaceutical and fine chemical sectors through its advanced asymmetric synthesis technologies. Founded in Japan in 1920, the company specializes in the development and manufacture of chiral intermediates and active pharmaceutical ingredients (APIs) using proprietary catalyst technologies like BINAP. Their Core-Chiral technology platform enables the production of high-purity enantiomers essential for modern drug development. Takasago operates as a key Contract Manufacturing Organization (CMO) for global pharmaceutical companies, providing scalable solutions from R&D to commercial production. Beyond healthcare, they are a major supplier of aroma chemicals and food flavors worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Takasago International.